amgunElevator Pitch I have a Buy rating assigned to Enfusion, Inc. (NYSE:ENFN) shares. My prior write-up published on November 8, 2023 highlighted Enfusion's above-expectations financial performance for the third quarter of last year. In the current article, I have found good reasons to be optimistic about ENFN's prospects pertaining to revenue growth acceleration and margin improvement. As such, I stick to my existing Buy rating for ENFN. Optimizing Customer Mix ENFN aims to have its revenue growth acc ...